Connect with us

Hi, what are you looking for?

Stock

KKR extends tender period for Fuji Soft to November

TOKYO (Reuters) – U.S. investment firm KKR has extended by 10 working days the first stage of its tender to take Japanese IT services firm Fuji Soft private, it said in a filing on Monday.

The first stage of the binding offer was previously due to expire on Monday, Oct. 21 but will now expire on Nov. 5. Fuji Soft shareholders will still have a second opportunity to tender to KKR’s offer after the first stage concludes.

Both stages are priced at 8,800 yen ($58.73) per share, around 7% lower than a rival binding proposal made by Bain Capital on Oct. 11 at 9,450 yen per share.

($1 = 149.8300 yen)

This post appeared first on investing.com






    You May Also Like

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com